Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.
Dessau-based company to now fill AstraZeneca COVID-19 vaccine - Merz Pharma is foregoing capacities at short notice more info
Overall, a total of 100 million euros are currently being invested in the site... more info
Takeda provides booked capacity at the IDT site in Dessau more info
Initial data for corona vaccine indicate good tolerability but weak immune response more info